» Articles » PMID: 19049553

Facioscapulohumeral Muscular Dystrophy: Hearing Loss and Other Atypical Features of Patients with Large 4q35 Deletions

Overview
Journal Eur J Neurol
Publisher Wiley
Specialty Neurology
Date 2008 Dec 4
PMID 19049553
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Patients affected by facioscapulohumeral muscular dystrophy (FSHD) with unusual large 4q35 deletions tend to present atypical features in early childhood. We explored the clinical presentation of patients with a very short 4q35 fragment (10-13 kb) focusing on hearing loss, a still debated FSHD extra-muscular manifestation.

Patients And Methods: We evaluated six cases with EcoRI 4q35 fragment size ranging from 10 to 13 kb. Assessment of hearing function was carried out by otoscopy, audiometry and auditory-evoked brainstem responses (ABR). Patient data were compared with those of 28 similar subjects reported in the literature.

Results: Sensorineural hearing loss was found in four patients, who presented infantile-onset dystrophic phenotype. Hearing loss was associated with mental retardation in three of them and with epilepsy in two. Auditory ability of the other two cases was mildly impaired. If findings related to 28 similar cases reported to date are also considered, auditory impairment appears evident in 68% of these subjects.

Conclusions: Hearing loss represents a characteristic feature of FSHD patients with a large 4q35 deletion. Moreover, when considering only cases with 10-11 kb, it appears to be associated with early-onset dystrophic phenotype, with mental retardation (92%) and possibly with epilepsy (58%).

Citing Articles

Longitudinal Insights Into Childhood Onset Facioscapulohumeral Dystrophy: A 5-Year Natural History Study.

Dijkstra J, Boon H, Koekkoek A, Goselink R, Pelsma M, van Alfen N Neurology. 2024; 104(1):e210059.

PMID: 39689340 PMC: 11655134. DOI: 10.1212/WNL.0000000000210059.


Gastrointestinal cancer occurs as extramuscular manifestation in FSHD1 patients.

Kurashige T, Morino H, Ueno H, Murao T, Watanabe T, Hinoi T J Hum Genet. 2022; 68(2):91-95.

PMID: 36336708 PMC: 9873551. DOI: 10.1038/s10038-022-01095-0.


Natural History of Facioscapulohumeral Dystrophy in Children: A 2-Year Follow-up.

Dijkstra J, Goselink R, van Alfen N, de Groot I, Pelsma M, van der Stoep N Neurology. 2021; 97(21):e2103-e2113.

PMID: 34675094 PMC: 8610619. DOI: 10.1212/WNL.0000000000012882.


Early-Onset Infantile Facioscapulohumeral Muscular Dystrophy: A Timely Review.

Chen T, Wu Y, Tseng Y Int J Mol Sci. 2020; 21(20).

PMID: 33096728 PMC: 7589635. DOI: 10.3390/ijms21207783.


Ophthalmological findings in facioscapulohumeral dystrophy.

Goselink R, Schreur V, van Kernebeek C, Padberg G, van der Maarel S, van Engelen B Brain Commun. 2020; 1(1):fcz023.

PMID: 32954265 PMC: 7425335. DOI: 10.1093/braincomms/fcz023.